Informaçao sobre o Autor

Sychev, D. A

Edição Seção Título Arquivo
Nº 13 (2015) Articles Chastota naznacheniya potentsial'no ne rekomendovannykh lekarstvennykh preparatov (po kriteriyam «STOPP START») pozhilym patsientam, nakhodyashchimsya v terapevticheskikh otdeleniyakh statsionara: rezul'taty farmakoepidemiologicheskogo issledovaniya
Volume 27, Nº 5 (2020) Articles «PharmaCOVID» - information center for pharmacotherapy of patients with new coronavirus infection COVID-19
Volume 27, Nº 5 (2020) Articles Drug-induced diseases: epidemiology and urgency of the problem
Volume 27, Nº 6 (2020) Articles Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance
Volume 27, Nº 14 (2020) Articles Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19
Volume 28, Nº 1 (2021) Articles The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide
Volume 28, Nº 1 (2021) Articles Possibility and prospects of using bamlanivimab in patients with COVID-19
Volume 28, Nº 3 (2021) Articles Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system
Volume 28, Nº 3 (2021) Articles The influence of CYP2C9 gene polymorphisms on the efficacy of losartan in patients with grade I-II arterial hypertension
Volume 28, Nº 3 (2021) Articles Carriage of the COMT rs4680 polymorphic variant is associated with better tolerance to antipsychotics in adolescents with an acute psychotic episode: a prospective observational clinical study
Volume 28, Nº 5 (2021) Articles Tobacco smoking as a risk factor for the development of drug-induced diseases
Volume 28, Nº 9 (2021) Articles Polymorphic variants of the ANKS1B rs7968606 (C>T) and ZNF804A rs1344706 (G>T) genes are not associated with the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
Volume 28, Nº 9 (2021) Articles HTR2A rs6313 polymorphic variant is associated with adverse effects to antipsychotics in adolescents with an acute psychotic episode
Volume 28, Nº 10 (2021) Articles Potentials for the use of glucocorticosteroids in inpatients with severe COVID-19
Volume 28, Nº 11 (2021) Articles Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors
Volume 28, Nº 11 (2021) Articles Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
Volume 28, Nº 11 (2021) Articles Medication errors as risk factor for drug-induced diseases
Volume 28, Nº 12 (2021) Articles Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19
Volume 28, Nº 12 (2021) Articles Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
Volume 28, Nº 13 (2021) Articles Drug-alcohol interactions: focus on central-acting drugs and analgesics
Volume 28, Nº 13 (2021) Articles Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs
Volume 28, Nº 13 (2021) Articles Effect of CYP2C9 gene polymorphism on losartan dosage regimen in patients with I-II degree arterial hypertension
Volume 29, Nº 1 (2022) Articles Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions
Volume 29, Nº 3 (2022) Articles Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence
Volume 29, Nº 3 (2022) Articles Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status
Volume 29, Nº 13 (2022) Articles Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins